Skip to main content
Fig. 5 | Molecular Medicine

Fig. 5

From: Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversion

Fig. 5

Prioritized Drug Targets’ Pathways and Binding. Top enriched GO:MF pathways of targets from 16 prioritized drugs by p-adjusted value as (A) a barplot and (B–E) specific pathways shown as networks of prioritized drugs (orange rectangular nodes) and their targets (red circular nodes) with color shade defined by the number of connections to other nodes

Back to article page